Clinical Trials Sponsored by Emergex Vaccines Holding Ltd.

Total 3 results

Emergex Vaccines Holding Ltd.

Not yet recruiting

Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)

COVID-19 | Coronavirus | SARS-CoV-2 Infection

Philippines
Emergex Vaccines Holding Ltd.
University of Lausanne Hospitals; Center for Primary Care and Public Health...

Completed

A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against Dengue Virus

Dengue

Switzerland
Emergex Vaccines Holding Ltd.
University of Lausanne Hospitals; Center for Primary Care and Public Health...

Completed

A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2

COVID-19 | Coronavirus | SARS-CoV-2 Infection

Switzerland

3

Subscribe